Connection

Mark Rubinstein to Humans

This is a "connection" page, showing publications Mark Rubinstein has written about Humans.
Connection Strength

0.444
  1. Selective suppression of de novo SARS-CoV-2 vaccine antibody responses in patients with cancer on B cell-targeted therapy. JCI Insight. 2023 Mar 22; 8(6).
    View in: PubMed
    Score: 0.033
  2. Converting Tumoral PD-L1 into a 4-1BB Agonist for Safer and More Effective Cancer Immunotherapy. Cancer Discov. 2022 05 02; 12(5):1184-1186.
    View in: PubMed
    Score: 0.031
  3. Phase I Trial Characterizing the Pharmacokinetic Profile of N-803, a Chimeric IL-15 Superagonist, in Healthy Volunteers. J Immunol. 2022 03 15; 208(6):1362-1370.
    View in: PubMed
    Score: 0.031
  4. ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial. Lancet Oncol. 2018 05; 19(5):694-704.
    View in: PubMed
    Score: 0.024
  5. IL-2 and Beyond in Cancer Immunotherapy. J Interferon Cytokine Res. 2018 02; 38(2):45-68.
    View in: PubMed
    Score: 0.023
  6. Effector CD8+ T-cell Engraftment and Antitumor Immunity in Lymphodepleted Hosts Is IL7Ra Dependent. Cancer Immunol Res. 2015 Dec; 3(12):1364-74.
    View in: PubMed
    Score: 0.020
  7. IL-12 conditioning improves retrovirally mediated transduction efficiency of CD8+ T cells. Cancer Gene Ther. 2015 Jul; 22(7):360-7.
    View in: PubMed
    Score: 0.020
  8. Interleukin-12 enhances the function and anti-tumor activity in murine and human CD8(+) T cells. Cancer Immunol Immunother. 2015 May; 64(5):539-49.
    View in: PubMed
    Score: 0.019
  9. G-CSF/anti-G-CSF antibody complexes drive the potent recovery and expansion of CD11b+Gr-1+ myeloid cells without compromising CD8+ T cell immune responses. J Hematol Oncol. 2013 Oct 01; 6:75.
    View in: PubMed
    Score: 0.017
  10. Soluble IL-15/IL-15Ra complexes in human serum. Blood. 2012 Jul 05; 120(1):1-2.
    View in: PubMed
    Score: 0.016
  11. IL-7 and IL-15 differentially regulate CD8+ T-cell subsets during contraction of the immune response. Blood. 2008 Nov 01; 112(9):3704-12.
    View in: PubMed
    Score: 0.012
  12. Converting IL-15 to a superagonist by binding to soluble IL-15R{alpha}. Proc Natl Acad Sci U S A. 2006 Jun 13; 103(24):9166-71.
    View in: PubMed
    Score: 0.010
  13. Applications of contact lens devices in the management of corneal disease. Eye (Lond). 2003 Nov; 17(8):872-6.
    View in: PubMed
    Score: 0.009
  14. Critical evaluation of an autologous peripheral blood mononuclear cell-based humanized cancer model. PLoS One. 2022; 17(9):e0273076.
    View in: PubMed
    Score: 0.008
  15. B cells imprint adoptively transferred CD8+ T cells with enhanced tumor immunity. J Immunother Cancer. 2022 01; 10(1).
    View in: PubMed
    Score: 0.008
  16. COVID-19 mRNA booster vaccines elicit strong protection against SARS-CoV-2 Omicron variant in patients with cancer. Cancer Cell. 2022 02 14; 40(2):117-119.
    View in: PubMed
    Score: 0.008
  17. Neoadjuvant presurgical PD-1 inhibition in oral cavity squamous cell carcinoma. Cell Rep Med. 2021 10 19; 2(10):100426.
    View in: PubMed
    Score: 0.008
  18. Modeling ex vivo tumor-infiltrating lymphocyte expansion from established solid malignancies. Oncoimmunology. 2021; 10(1):1959101.
    View in: PubMed
    Score: 0.007
  19. Differential immune signatures in the tumor microenvironment are associated with colon cancer racial disparities. Cancer Med. 2021 03; 10(5):1805-1814.
    View in: PubMed
    Score: 0.007
  20. Identification of human CD4+ T cell populations with distinct antitumor activity. Sci Adv. 2020 07; 6(27).
    View in: PubMed
    Score: 0.007
  21. IL6 Fuels Durable Memory for Th17 Cell-Mediated Responses to Tumors. Cancer Res. 2020 09 15; 80(18):3920-3932.
    View in: PubMed
    Score: 0.007
  22. Ex vivo blockade of PI3K gamma or delta signaling enhances the antitumor potency of adoptively transferred CD8+ T cells. Eur J Immunol. 2020 09; 50(9):1386-1399.
    View in: PubMed
    Score: 0.007
  23. Distance telescopes: a survey of user success. Optom Vis Sci. 2000 May; 77(5):260-9.
    View in: PubMed
    Score: 0.007
  24. Thrombin contributes to cancer immune evasion via proteolysis of platelet-bound GARP to activate LTGF-?. Sci Transl Med. 2020 01 08; 12(525).
    View in: PubMed
    Score: 0.007
  25. Anti-CTLA-4 Activates Intratumoral NK Cells and Combined with IL15/IL15Ra Complexes Enhances Tumor Control. Cancer Immunol Res. 2019 08; 7(8):1371-1380.
    View in: PubMed
    Score: 0.006
  26. Fueling Cancer Immunotherapy With Common Gamma Chain Cytokines. Front Immunol. 2019; 10:263.
    View in: PubMed
    Score: 0.006
  27. Recent updates in cancer immunotherapy: a comprehensive review and perspective of the 2018 China Cancer Immunotherapy Workshop in Beijing. J Hematol Oncol. 2018 12 21; 11(1):142.
    View in: PubMed
    Score: 0.006
  28. The clinical implications of immunogenomics in colorectal cancer: A path for precision medicine. Cancer. 2018 04 15; 124(8):1650-1659.
    View in: PubMed
    Score: 0.006
  29. Vaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancer. J Hematol Oncol. 2017 04 07; 10(1):82.
    View in: PubMed
    Score: 0.006
  30. A Novel Fusion of ALT-803 (Interleukin (IL)-15 Superagonist) with an Antibody Demonstrates Antigen-specific Antitumor Responses. J Biol Chem. 2016 Nov 11; 291(46):23869-23881.
    View in: PubMed
    Score: 0.005
  31. Lack of p53 Augments Antitumor Functions in Cytolytic T Cells. Cancer Res. 2016 09 15; 76(18):5229-5240.
    View in: PubMed
    Score: 0.005
  32. Effect of administration timing of postchemotherapy granulocyte colony-stimulating factor on host-immune cell recovery and CD8+ T-cell response. J Immunotoxicol. 2016 11; 13(6):784-792.
    View in: PubMed
    Score: 0.005
  33. Exploiting IL-17-producing CD4+ and CD8+ T cells to improve cancer immunotherapy in the clinic. Cancer Immunol Immunother. 2016 Mar; 65(3):247-59.
    View in: PubMed
    Score: 0.005
  34. Dendritic Cells in Irradiated Mice Trigger the Functional Plasticity and Antitumor Activity of Adoptively Transferred Tc17 Cells via IL12 Signaling. Clin Cancer Res. 2015 Jun 01; 21(11):2546-57.
    View in: PubMed
    Score: 0.005
  35. Levels of visual impairment in a day centre for people with a mental handicap. J R Soc Med. 1991 Sep; 84(9):542-4.
    View in: PubMed
    Score: 0.004
  36. Microtropia versus bifoveal fixation in anisometropic amblyopia. Eye (Lond). 1991; 5 ( Pt 5):576-84.
    View in: PubMed
    Score: 0.004
  37. Mature natural killer cells with phenotypic and functional alterations accumulate upon sustained stimulation with IL-15/IL-15Ralpha complexes. Proc Natl Acad Sci U S A. 2010 Dec 14; 107(50):21647-52.
    View in: PubMed
    Score: 0.004
  38. Corneal epithelial oxygen uptake rate in diabetes mellitus. Eye (Lond). 1990; 4 ( Pt 5):757-9.
    View in: PubMed
    Score: 0.003
  39. Surviving the crash: transitioning from effector to memory CD8+ T cell. Semin Immunol. 2009 Apr; 21(2):92-8.
    View in: PubMed
    Score: 0.003
  40. The sensitive period for anisometropic amblyopia. Eye (Lond). 1989; 3 ( Pt 6):783-90.
    View in: PubMed
    Score: 0.003
  41. Interleukin-15/interleukin-15R alpha complexes promote destruction of established tumors by reviving tumor-resident CD8+ T cells. Cancer Res. 2008 Apr 15; 68(8):2972-83.
    View in: PubMed
    Score: 0.003
  42. The arthroscopic treatment of subacromial impingement. Clin Sports Med. 1987 Jul; 6(3):573-9.
    View in: PubMed
    Score: 0.003
  43. Review: novel nonviral delivery approaches for interleukin-12 protein and gene systems: curbing toxicity and enhancing adjuvant activity. J Interferon Cytokine Res. 2006 Sep; 26(9):593-608.
    View in: PubMed
    Score: 0.003
  44. CD8-independent tumor cell recognition is a property of the T cell receptor and not the T cell. J Immunol. 2003 Mar 01; 170(5):2582-9.
    View in: PubMed
    Score: 0.002
  45. The visually evoked subcortical potential to flash stimulation in normal subjects and patients with lesions of the visual pathway. Adv Neurol. 1982; 32:31-9.
    View in: PubMed
    Score: 0.002
  46. The visually evoked subcortical potential: is related to the electroretinogram? Invest Ophthalmol Vis Sci. 1981 Aug; 21(2):335-44.
    View in: PubMed
    Score: 0.002
  47. The scalp topography of the human visually evoked subcortical potential. Invest Ophthalmol Vis Sci. 1980 Mar; 19(3):318-21.
    View in: PubMed
    Score: 0.002
  48. The optics of fundus examination. Surv Ophthalmol. 1992 May-Jun; 36(6):439-45.
    View in: PubMed
    Score: 0.001
  49. Determination of the nodal point position in the pseudophakic eye. Ophthalmic Physiol Opt. 1991 Apr; 11(2):105-8.
    View in: PubMed
    Score: 0.001
  50. Aniseikonia: a method of objective assessment in pseudophakia using geometric optics. Ophthalmic Physiol Opt. 1991 Apr; 11(2):109-12.
    View in: PubMed
    Score: 0.001
  51. White light interferometry in amblyopic children--a pilot study. Eye (Lond). 1990; 4 ( Pt 6):802-5.
    View in: PubMed
    Score: 0.001
  52. Calculated versus A-scan result for axial length using different types of ultrasound probe tip. Eye (Lond). 1990; 4 ( Pt 5):718-22.
    View in: PubMed
    Score: 0.001
  53. Pseudophakic accommodation? A study of the stability of capsular bag supported, one piece, rigid tripod, or soft flexible implants. Br J Ophthalmol. 1990 Jan; 74(1):22-5.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.